References
- Osler W. The study of the Fevers of the South. JAMA 21, 999–1004 (1896).
- Osler W. The evolution of modern medicine. (1904).
- Otero RM, Nguyen HB, Huang DT et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 130 (5), 1579–1595 (2006).
- Rivers E, Nguyen B, Havstad S et al.; Early Goal-Directed Therapy Collaborative G. Early goal-directed therapy in the treatment of severe sepsis and septic shock. New Engl. J Med. 345 (19), 1368–1377 (2001).
- Kumar A, Roberts D, Wood KE et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit. Care Med. 34(6), 1589–1596 (2006).
- Shapiro N, Howell MD, Bates DW, Angus DC, Ngo L, Talmor D. The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. [see comment]. Ann. Emerg. Med. 48(5), 583–590.
- Slade E, Tamber PS, Vincent J-L. The surviving sepsis campaign: raising awareness to reduce mortality. Crit. Care 7(1), 1 (2003).
- Angus DC, Linde-Zwirble WT, Lidicker J et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit. Care Med. 29(7), 1303–1310 (2001).
- Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit. Care Med. 41(5), 1167–1174 (2013).
- Whittaker SA, Mikkelsen ME, Gaieski DF, Koshy S, Kean C, Fuchs BD. Severe sepsis cohorts derived from claims-based strategies appear to be biased toward a more severely ill patient population. Crit. Care Med. 41(4), 945–953 (2013).
- Jones AE, Shapiro NI, Trzeciak S, Arnold RC, Claremont HA, Kline JA. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy. JAMA 308(8), 739–746 (2010).
- Schortgen F, Clabault K, Katsahian S et al. Fever control using external cooling in septic shock: a randomized controlled trial. Am. J. Respir. Crit. Care Med. 185(10), 1088–1095 (2012).
- Bone RC, FisherCJJr, Clemmer TP, Slotman GJ, Metz CA, Balk RA; Methylprednisolone Severe Sepsis Study Group. Sepsis syndrome: a valid clinical entity. Crit. Care Med. 17(5), 389–393 (1989).
- Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101(6), 1644–1655 (1992).
- Bone RC. Let's agree on terminology: definitions of sepsis [see comment]. Crit. Care Med. 19(7), 973–976 (1991).
- Sibbald WJ, Marshall J, Christou N et al. ‘Sepsis’ – clarity of existing terminology ... or more confusion? Crit. Care Med. 19(8), 996–998 (1991).
- Sprung CL. Definitions of sepsis–have we reached a consensus? Crit. Care Med. 19(7), 849–851 (1991).
- The Veterans Administration Systemic Sepsis Cooperative Study Group. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. New Engl. J. Med. 317(11), 659–665 (1987).
- Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273(2), 117–123 (1995).
- Vincent JL. Dear SIRS, I'm sorry to say that I don't like you. Crit. Care Med. 25(2), 372–374 (1997).
- Levy MM, Fink MP, Marshall JC et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med. 29(4), 530–538 (2003).
- Mikkelsen ME, Miltiades AN, Gaieski DF et al. Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit. Care Med. 37(5), 1670–1677 (2009).